Global Information
회사소개 | 문의 | 비교리스트

감기 및 인플루엔자 치료제 : 세계 시장 전망(2018-2027년)

Cold & Flu Drugs - Global Market Outlook (2018-2027)

리서치사 Stratistics Market Research Consulting
발행일 2020년 05월 상품 코드 939177
페이지 정보 영문 145 Pages
가격
US $ 4,150 ₩ 4,734,000 PDF (Single User License)
US $ 5,250 ₩ 5,989,000 PDF (2-5 User License)
US $ 6,350 ₩ 7,244,000 PDF (Site License)
US $ 7,500 ₩ 8,556,000 PDF (Global Site License)


감기 및 인플루엔자 치료제 : 세계 시장 전망(2018-2027년) Cold & Flu Drugs - Global Market Outlook (2018-2027)
발행일 : 2020년 05월 페이지 정보 : 영문 145 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 감기 및 인플루엔자 치료제 시장은 2018년에 127억 8,000만 달러를 기록했습니다. 이 시장은 예측 기간 중 8.4%의 CAGR로 성장할 전망이며, 2027년에는 264억 달러에 달할 것으로 예측되고 있습니다. 시장 성장을 촉진하는 주요 요인에는 폭음·폭식의 증가, 정크푸드의 소비, 정기적인 운동부족, 스트레스의 증가 등을 들 수 있습니다.

세계의 감기 및 인플루엔자 치료제 시장에 대해 조사했으며, 시장 기회 및 동향, 성장 및 억제요인, 제품 유형·용도·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 서론

제3장 시장 동향 분석

  • 서론
  • 성장요인
  • 억제요인
  • 시장 기회
  • 위협
  • 제품 분석
  • 용도 분석
  • 신흥 시장
  • 신종 코로나바이러스 감염증의 영향

제4장 Porter의 산업 분석

제5장 세계 시장 : 제품 유형

  • 서론
  • 충혈 제거제
  • 항생제
  • 항히스타민제
  • 거담약
  • 기관지 확장약

제6장 세계 시장 : 용도별

  • 서론
  • 처방전
  • 시판(OTC) 약

제7장 세계 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동·아프리카

제8장 주요 발전

  • 계약, 제휴, 협업, 합병사업
  • 인수합병
  • 신제품 발매
  • 확장
  • 기타 주요 전략

제9장 기업 개요

  • Bayer
  • AstraZeneca
  • Procter and Gamble
  • Reckitt Benckiser Group
  • Johnson & Johnson
  • GlaxoSmithKline
  • Novartis
  • Sun Pharmaceutical Industries
  • Pfizer
  • Prestige Brands Holdings
KSA 20.06.12

List of Tables

  • Table 1 Global Cold & Flu Drugs Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 3 Global Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 4 Global Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 5 Global Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 6 Global Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 7 Global Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 8 Global Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 9 Global Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 10 Global Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
  • Table 11 North America Cold & Flu Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 12 North America Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 13 North America Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 14 North America Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 15 North America Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 16 North America Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 17 North America Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 18 North America Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 19 North America Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 20 North America Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
  • Table 21 Europe Cold & Flu Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 22 Europe Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 23 Europe Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 24 Europe Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 25 Europe Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 26 Europe Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 27 Europe Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 28 Europe Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 29 Europe Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 30 Europe Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
  • Table 31 Asia Pacific Cold & Flu Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 32 Asia Pacific Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 33 Asia Pacific Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 34 Asia Pacific Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 35 Asia Pacific Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 36 Asia Pacific Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 37 Asia Pacific Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 38 Asia Pacific Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 39 Asia Pacific Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 40 Asia Pacific Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
  • Table 41 South America Cold & Flu Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 42 South America Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 43 South America Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 44 South America Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 45 South America Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 46 South America Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 47 South America Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 48 South America Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 49 South America Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 50 South America Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)
  • Table 51 Middle East & Africa Cold & Flu Drugs Market Outlook, By Country (2017-2027) ($MN)
  • Table 52 Middle East & Africa Cold & Flu Drugs Market Outlook, By Product Type (2017-2027) ($MN)
  • Table 53 Middle East & Africa Cold & Flu Drugs Market Outlook, By Decongestants (2017-2027) ($MN)
  • Table 54 Middle East & Africa Cold & Flu Drugs Market Outlook, By Antibiotics (2017-2027) ($MN)
  • Table 55 Middle East & Africa Cold & Flu Drugs Market Outlook, By Antihistamines (2017-2027) ($MN)
  • Table 56 Middle East & Africa Cold & Flu Drugs Market Outlook, By Expectorants (2017-2027) ($MN)
  • Table 57 Middle East & Africa Cold & Flu Drugs Market Outlook, By Bronchodilators (2017-2027) ($MN)
  • Table 58 Middle East & Africa Cold & Flu Drugs Market Outlook, By Application (2017-2027) ($MN)
  • Table 59 Middle East & Africa Cold & Flu Drugs Market Outlook, By Rx Drugs (2017-2027) ($MN)
  • Table 60 Middle East & Africa Cold & Flu Drugs Market Outlook, By Over the Counter (OTC) Drugs (2017-2027) ($MN)

According to Stratistics MRC, the Global Cold & Flu Drugs Market is accounted for $12.78 billion in 2018 and is expected to reach $26.40 billion by 2027 growing at a CAGR of 8.4% during the forecast period. Some of the key factors propelling the market growth include increasing cases of obesity all over the globe, increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress. However, cold & flu drugs may causes allergic reaction is likely to hamper the market.

Cold and Flu is a most common diseases infect to human. People think cold and flu is not major but sometimes it may be harmful for those. Due this awareness Cold and Flu Drugs is on demand. Cold and Flu Drugs are easily available in any medical store and less expense.

By application, over the counter (OTC) drugs segment is poised to witness lucrative growth over the forecast timeframe, due to increasing prevalence of digestion disorders, common flu, and cold. Over-the-counter (OTC) drugs also called as non-prescription drugs are medicines that do not require prescription from healthcare professionals for selling it to consumers. These drugs are available at pharmacies, supermarkets, general stores, and gas stations across several countries. However, these drugs are solely authorized for dispense by pharmacists, after confirming age, identity, and patient's knowledge regarding the product and its utility.

On the basis of geography, Asia Pacific region is projected to have considerable market growh during the forecast period, owing to growing patient awareness regarding consumption of OTC drugs, leading to self-medication practices. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.

Some of the key players in cold & flu drugs market include Bayer, AstraZeneca, Procter and Gamble, Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Sun Pharmaceutical Industries, Pfizer, and Prestige Brands Holdings.

Product Types Covered:

  • Decongestants
  • Antibiotics
  • Antihistamines
  • Expectorants
  • Bronchodilators

Applications Covered:

  • Rx Drugs
  • Over the Counter (OTC) Drugs

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cold & Flu Drugs Market, By Product Type

  • 5.1 Introduction
  • 5.2 Decongestants
  • 5.3 Antibiotics
  • 5.4 Antihistamines
  • 5.5 Expectorants
  • 5.6 Bronchodilators

6 Global Cold & Flu Drugs Market, By Application

  • 6.1 Introduction
  • 6.2 Rx Drugs
  • 6.3 Over the Counter (OTC) Drugs

7 Global Cold & Flu Drugs Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Bayer
  • 9.2 AstraZeneca
  • 9.3 Procter and Gamble
  • 9.4 Reckitt Benckiser Group
  • 9.5 Johnson & Johnson
  • 9.6 GlaxoSmithKline
  • 9.7 Novartis
  • 9.8 Sun Pharmaceutical Industries
  • 9.9 Pfizer
  • 9.10 Prestige Brands Holdings
Back to Top
전화 문의
F A Q